Skip to main content

Table 2 Comparison of endpoints at six weeks expressed as changes from baseline.

From: Concentrated oat β-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial

  Treatment Placebo P value
Total Cholesterol (mmol/L) -0.3 ± 0.1 *** -0.1 ± 0.08 0.184
LDL cholesterol (mmol/L)** -0.3 ± 0.1 *** -0.04 ± 0.08 0.026
HDL cholesterol (mmol/L) -0.02 ± 0.02 -0.009 ± 0.02 0.842
Triglyceride (mmol/L)* 0.09 ± 0.1 -0.2 ± 0.1*** 0.030
Cholesterol/HDL ratio -0.2 ± 0.1 -0.1 ± 0.1 0.947
C-Reactive protein (mg/dL) -0.03 ± 0.06 0.01 ± 0.04 0.546
Homocysteine (μM/L) 0.4 ± 0.4 0.2 ± 0.2 0.528
Insulin (pmol/L) 6.9 ± 4.9 4.2 ± 10.4 0.804
Glucose (mmol/L) 0.2 ± 0.09 0.03 ± 0.09 0.259
Weight (kg) -0.7 ± 0.3 1.4 ± 1.3 0.117
Blood pressure (systolic/diastolic, mmHg, value at end point) 119/69 ± 1.9/1.3 119/69 ± 2.0/1.7 0.832/0.856
Total Energy Intake per day (kJ) -519 ± 330 -343 ± 360 0.724
Carbohydrate intake (% of total) 0.4 ± 2.0 1.8 ± 1.3 0.535
Protein Intake (% of total) 0.9 ± 0.6 -0.9 ± 1.1 0.041
Fat Intake (% of total) -0.7 ± 1.8 -1.2 ± 1.1 0.784
Dietary Fiber Intake (grams) -0.3 ± 1.1 -1.4 ± 1.6 0.454
  1. Data are means ± SEM.
  2. ***Statistically different from baseline, within group comparison p < 0.05